Visit the AHRP blog:
http://ahrp.blogspot.com
Conflict of Interest - Public Policy
Vioxx Redux: FDA on the Sidelines as Marketing Subsumes Evidence: Surviving Sepsis-NEJM PDF Print E-mail
Saturday, 21 October 2006
Lilly's aggressive marketing of Xigris does indeed epitomize the worst ofthis industry's mission.
Read more...
 
Press Coverage of Xigris NEJM article PDF Print E-mail
Thursday, 19 October 2006
"Academic officials acknowledged in the published guidelines that Lilly gave more than 90 percent of $861,000 in grants for the campaign and medical recommendations. About a fifth of the 46 guidelines writers acknowledged previously taking money from Eli Lilly for speaking, consulting or research."
Read more...
 
Legislation Seeks Access to Tax-Funded Research_WashPost PDF Print E-mail
Thursday, 04 May 2006
Congress is finally addressing a rip-off by scientists who redeive taxpayer money and don't show their findings to the public.
Read more...
 
FDA Staff Travels on Drug Industry Dollars PDF Print E-mail
Thursday, 30 March 2006
The Center for Public Integrity reports that FDA officials circumvent the prohibition on accepting trips from drug and medical device manufacturers.
Read more...
 
Bill Frist's most Frequent Corporate Flight Hosts--Pharmaceutical companies PDF Print E-mail
Thursday, 09 March 2006
The nation's most powerful legislators have grown accustomed to riding in plush private coporate jets. How does that affect public policy?
Read more...
 
<< Start < Prev 1 2 Next > End >>

Results 10 - 16 of 16
(C) 2008 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]